Allgens Medical Technology Co (SHSE:688613) Other Financing: ¥-2.2 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688613 Allgens Medical Technology Co Ltd SHSE:688613
63 GF Score
Price ¥15.62
GF Value ¥22.25
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Allgens Medical Technology Co Other Financing?

Allgens Medical Technology Co SHSE:688613 -0.06% 63 Other Financing is ¥-2.2 Mil as of Jun. 2026. GuruFocus rates SHSE:688613 with a GF Score™ of 63/100 and a GF Value™ of ¥22.25 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Allgens Medical Technology Co's Other Financing for the three months ended in Jun. 2026 was ¥-1.5 Mil.

Allgens Medical Technology Co's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ¥-2.2 Mil.

Allgens Medical Technology Co Other Financing Historical Data

* Premium members only.

The historical data trend for Allgens Medical Technology Co's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allgens Medical Technology Co Other Financing Chart

Allgens Medical Technology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only 478.42 -7.07 -8.11 21.85 13.24

Allgens Medical Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.68 0.00 -0.44 -0.23 -1.49
SHSE:688613
63GF Score
Allgens Medical Technology Co Ltd SHSE:688613
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allgens Medical Technology Co Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ¥-2.2 Mil mean?
Allgens Medical Technology Co (SHSE:688613) has a Other Financing of ¥-2.2 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Allgens Medical Technology Co and its competitors.
Is Allgens Medical Technology Co's Other Financing too high?
Allgens Medical Technology Co's current Other Financing is ¥-2.2 Mil. Overall, Allgens Medical Technology Co has a GF Score™ of 63/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Allgens Medical Technology Co's Other Financing compare to ABT and SYK?
Allgens Medical Technology Co's Other Financing of ¥-2.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Allgens Medical Technology Co and its competitors. Allgens Medical Technology Co's current Other Financing is ¥-2.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allgens Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Allgens Medical Technology Co (SHSE:688613) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥22.25, compared to a current price of ¥15.62 — trading 29.8% below its estimated fair value. The current Other Financing is ¥-2.2 Mil. Allgens Medical Technology Co's overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Allgens Medical Technology Co (SHSE:688613), the current Other Financing is ¥-2.2 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allgens Medical Technology Co (SHSE:688613) Overvalued in 2026?

Based on GuruFocus' analysis, Allgens Medical Technology Co stock appears to be undervalued. The current stock price of ¥15.62 is trading 29.8% below its estimated GF Value™ of ¥22.25. GuruFocus considers Allgens Medical Technology Co to be Significantly Undervalued.

Key valuation signals for SHSE:688613:

  • Other Financing: ¥-2.2 Mil
  • GF Value™: ¥22.25 vs. price of ¥15.62 (29.8% below fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688613 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allgens Medical Technology Co Business Description

Address No. 5, Kaixing Road, A305, 3rd Floor, Haidian District, Beijing, CHN, 102609
Allgens Medical Technology Co Ltd is engaged in the research and development, production and sales of high-end biomedical materials and related medical device products.
63GF Score

Get the complete analysis for SHSE:688613

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.62
Price
¥22.25
GF Value